BRPI0716580A2 - TREATMENT OF FIBROSANT DISORDERS - Google Patents

TREATMENT OF FIBROSANT DISORDERS

Info

Publication number
BRPI0716580A2
BRPI0716580A2 BRPI0716580-3A2A BRPI0716580A BRPI0716580A2 BR PI0716580 A2 BRPI0716580 A2 BR PI0716580A2 BR PI0716580 A BRPI0716580 A BR PI0716580A BR PI0716580 A2 BRPI0716580 A2 BR PI0716580A2
Authority
BR
Brazil
Prior art keywords
fibrosant
disorders
treatment
fibrosant disorders
Prior art date
Application number
BRPI0716580-3A2A
Other languages
Portuguese (pt)
Inventor
Ruey-Shiuan Tsai
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/EP2007/007332 external-priority patent/WO2008022761A2/en
Publication of BRPI0716580A2 publication Critical patent/BRPI0716580A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0716580-3A2A 2006-08-22 2007-08-20 TREATMENT OF FIBROSANT DISORDERS BRPI0716580A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119311 2006-08-22
PCT/EP2007/007332 WO2008022761A2 (en) 2006-08-22 2007-08-20 Rapamycin and its derivatives for the treatment of liver-associated fibrosing disorders

Publications (1)

Publication Number Publication Date
BRPI0716580A2 true BRPI0716580A2 (en) 2013-10-08

Family

ID=37670639

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0716580-3A2A BRPI0716580A2 (en) 2006-08-22 2007-08-20 TREATMENT OF FIBROSANT DISORDERS

Country Status (2)

Country Link
CN (1) CN101553228A (en)
BR (1) BRPI0716580A2 (en)

Also Published As

Publication number Publication date
CN101553228A (en) 2009-10-07

Similar Documents

Publication Publication Date Title
BRPI0811265A2 (en) TREATMENT OF SYNUCLEINOPATHIES
SMAP200900085A (en) 3-imidazolyl-indoles for the treatment of malolysiseproliferative
PL3354276T3 (en) COMPOSITIONS FOR THE TREATMENT OF GIASMATIS
HUS1600048I1 (en) Preparation for the treatment of Fabry disease
EP1982660A4 (en) ENDOSCOPE OF TREATMENT
DK1874781T3 (en) Dihydrothienopyrimidines for the treatment of inflammatory diseases
HUE054495T2 (en) Preparation for the treatment of cancer
BRPI0716466A2 (en) TREATMENT OF SUGAR
DK2056807T3 (en) Treatment of inflammatory diseases
EP2046349A4 (en) TREATMENT OF EXCESSIVE NEOVASCULARIZATION
ES1063346Y (en) WALKER
BRPI0908026A2 (en) Methods for the treatment of bowel diseases
DE602007011342D1 (en) Endoscope treatment tool
BRPI0815551A2 (en) TREATMENT THROUGH HUCBC OF BETA-AMYLOID DISEASE
DE602007006594D1 (en) Endoscope treatment instrument
DK2056842T3 (en) Modified galactosylceramide for the treatment of cancerous diseases
PT2046324T (en) TREATMENT AND PREVENTION OF MUCOSITE BY ANTOCYANIDINE DERIVATIVES
PL2338519T3 (en) AGENT FOR THE TREATMENT OF MYMELFARIS
DK2035369T3 (en) THERAPEUTIC
PL1890684T3 (en) Treatment of sleep-wake disorders
DK1993589T3 (en) Treatments for neurological diseases
DK2173831T3 (en) WELL TREATMENT
EP2110789A4 (en) PROCESSOR OF PAPER-CURRENCY
BRPI0715728A8 (en) treatment of cartilage disorders
EP3381471C0 (en) PAIN TREATMENT

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2320 DE 23-06-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.